We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+2.93%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$136M
AUM Growth
+$1.33M
Cap. Flow
-$2.17M
Cap. Flow %
-1.59%
Top 10 Hldgs %
21.77%
Holding
187
New
33
Increased
43
Reduced
61
Closed
33

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$1.43M
2
MLM icon
Martin Marietta Materials
MLM
+$1.31M
3
EXPD icon
Expeditors International
EXPD
+$1.16M
4
LPX icon
Louisiana-Pacific
LPX
+$890K
5
CCL icon
Carnival Corporation Ltd
CCL
+$839K

Top Sells

Rank Stock Value
1
PRXL
Parexel International Corp
PRXL
+$2.14M
2
NSC icon
Norfolk Southern
NSC
+$1.25M
3
MS icon
Morgan Stanley
MS
+$1.13M
4
AMGN icon
Amgen
AMGN
+$1,000K
5
TD icon
Toronto Dominion Bank
TD
+$913K

Sector Composition

Rank Sector Weight
1 Industrials 23.47%
2 Healthcare 19.52%
3 Financials 17.24%
4 Consumer Staples 11.65%
5 Technology 11.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHD icon
1
Church & Dwight Co
CHD
$23.4B
$5.31M 3.89%
109,600
-4,100
-4% -$208K
JNJ icon
2
Johnson & Johnson
JNJ
$618B
$4.24M 3.1%
32,592
-23
-0.1% -$3.05K
WASH icon
3
Washington Trust Bancorp
WASH
$743M
$4.23M 3.1%
73,859
+1,050
+1% +$54.6K
PFE icon
4
Pfizer
PFE
$143B
$2.47M 1.81%
72,856
-1,189
-2% -$38.2K
CSCO icon
5
Cisco
CSCO
$457B
$2.36M 1.73%
70,225
+3,828
+6% +$122K
KMB icon
6
Kimberly-Clark
KMB
$36.3B
$2.36M 1.73%
20,038
-100
-0.5% -$12.2K
GE icon
7
GE Aerospace
GE
$374B
$2.3M 1.69%
19,861
-2,642
-12% -$319K
XOM icon
8
ExxonMobil
XOM
$644B
$2.24M 1.64%
27,298
– –
INTC icon
9
Intel
INTC
$455B
$2.17M 1.59%
56,985
-34
-0.1% -$1.21K
PB icon
10
Prosperity Bancshares
PB
$8.97B
$2.04M 1.49%
31,034
-1,106
-3% -$69.3K
INDB icon
11
Independent Bank
INDB
$3.99B
$1.96M 1.44%
26,265
-2,525
-9% -$176K
ZTS icon
12
Zoetis
ZTS
$32.4B
$1.94M 1.42%
30,418
+900
+3% +$56.4K
DIS icon
13
Walt Disney
DIS
$167B
$1.84M 1.35%
18,654
+3,075
+20% +$316K
AB icon
14
AllianceBernstein
AB
$3.43B
$1.82M 1.33%
74,778
+2,250
+3% +$54.2K
AAPL icon
15
Apple
AAPL
$4.54T
$1.74M 1.27%
45,096
+2,472
+6% +$95.9K
ALK icon
16
Alaska Air
ALK
$5.29B
$1.68M 1.23%
22,050
+9,925
+82% +$811K
MRK icon
17
Merck
MRK
$322B
$1.67M 1.22%
27,264
+12,629
+86% +$766K
WFC icon
18
Wells Fargo
WFC
$261B
$1.66M 1.22%
30,110
-1,350
-4% -$71.8K
TFC icon
19
Truist Financial
TFC
$63.3B
$1.6M 1.17%
34,090
-3,850
-10% -$177K
BEN icon
20
Franklin Resources
BEN
$17.6B
$1.6M 1.17%
35,900
+10,000
+39% +$438K
CCL icon
21
Carnival Corporation Ltd
CCL
$38.1B
$1.58M 1.16%
24,550
+12,550
+105% +$839K
CELG
22
DELISTED
Celgene Corp
CELG
$1.58M 1.16%
10,834
-350
-3% -$47.7K
BMY icon
23
Bristol-Myers Squibb
BMY
$133B
$1.57M 1.15%
24,617
-4,275
-15% -$250K
COST icon
24
Costco
COST
$422B
$1.52M 1.11%
9,250
+850
+10% +$134K
GILD icon
25
Gilead Sciences
GILD
$162B
$1.5M 1.1%
18,490
+2,050
+12% +$157K
1
2 3 4 5

Similar funds

GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
EBWM
Eagle Bluffs Wealth Management Columbia, Missouri $257M AUM 30.19% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return
PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
TC
Towle & Co Denver, Colorado $257M AUM 73.13% 1-Year Est. Return

New England Research & Management's Q3 2017 Portfolio in Review

As of Q3 2017, New England Research & Management held 187 positions worth $136M, up 0.98% from $135M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

New England Research & Management's Q3 2017 filing shows 33 new, 43 increased, 61 reduced and 33 closed positions. Its largest new stake was Medtronic: 17,182 shares worth $1.34M. The largest sale was Parexel International Corp, an estimated $2.14M.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • New England Research & Management's largest Q3 2017 buy was Medtronic: 17,182 shares worth $1.34M.
  • New England Research & Management added most to Carnival Corporation Ltd in Q3 2017, an estimated $839K increase.
  • New England Research & Management's biggest Q3 2017 reduction was Amgen, cutting an estimated $1,000K.
  • New England Research & Management fully exited Parexel International Corp in Q3 2017, selling an estimated $2.14M.
  • New England Research & Management's ten largest holdings make up 22% of its $136M portfolio in Q3 2017.
  • New England Research & Management opened 33 new positions and closed 33 in Q3 2017.
  • New England Research & Management's portfolio value rose 0.98% quarter-over-quarter to $136M.

Based on New England Research & Management's 13F filing for Q3 2017, filed 25 Oct 2017.